Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer

L Buscail, B Bournet, P Cordelier - Nature reviews Gastroenterology & …, 2020 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is predicted to be the second most common
cause of death within the next 10 years. The prognosis for this disease is poor despite …

Molecular and computational methods for the detection of microsatellite instability in cancer

LG Baudrin, JF Deleuze, A How-Kit - Frontiers in oncology, 2018 - frontiersin.org
Microsatellite instability (MSI) is a genomic alteration in which microsatellites, usually of one
to four nucleotide repeats, accumulate mutations corresponding to deletions/insertions of a …

Detection of low-frequency mutations in clinical samples by increasing mutation abundance via the excision of wild-type sequences

W Chen, H Xu, S Dai, J Wang, Z Yang, Y Jin… - Nature biomedical …, 2023 - nature.com
The efficiency of DNA-enrichment techniques is often insufficient to detect mutations that
occur at low frequencies. Here we report a DNA-excision method for the detection of low …

[HTML][HTML] NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi

C Charbel, RH Fontaine, GG Malouf, A Picard… - Journal of Investigative …, 2014 - Elsevier
Congenital melanocytic nevus (CMN) is a particular melanocytic in utero proliferation
characterized by an increased risk of melanoma transformation during infancy or adulthood …

Evaluation of droplet digital PCR and next generation sequencing for characterizing DNA reference material for KRAS mutation detection

L Dong, S Wang, B Fu, J Wang - Scientific reports, 2018 - nature.com
KRAS gene mutations are predictive markers of non-response to anti-epidermal growth
factor receptor. An increasing number of techniques are being developed to detect KRAS …

[HTML][HTML] Strategies for improving detection of circulating tumor DNA using next generation sequencing

R Tébar-Martínez, J Martín-Arana… - Cancer Treatment …, 2023 - Elsevier
Cancer has become a global health issue and liquid biopsy has emerged as a non-invasive
tool for various applications. In cancer, circulating tumor DNA (ctDNA) can be detected from …

Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis

S Mourah, A How-Kit, V Meignin… - European …, 2016 - Eur Respiratory Soc
The mitogen-activated protein kinase (MAPK) pathway is constantly activated in Langerhans
cell histiocytosis (LCH). Mutations of the downstream kinases BRAF and MAP2K1 mediate …

An ultrasensitive test for profiling circulating tumor DNA using integrated comprehensive droplet digital detection

CY Ou, T Vu, JT Grunwald, M Toledano, J Zimak… - Lab on a Chip, 2019 - pubs.rsc.org
Current cancer detection systems lack the required sensitivity to reliably detect minimal
residual disease (MRD) and recurrence at the earliest stages when treatment would be most …

Enhanced detection of microsatellite instability using pre-PCR elimination of wild-type DNA homo-polymers in tissue and liquid biopsies

I Ladas, F Yu, KW Leong, M Fitarelli-Kiehl… - Nucleic acids …, 2018 - academic.oup.com
Detection of microsatellite-instability in colonoscopy-obtained polyps, as well as in plasma-
circulating DNA, is frequently confounded by sensitivity issues due to co-existing excessive …

Technical considerations for circulating tumor DNA detection in oncology

C Franczak, P Filhine-Tresarrieu, P Gilson… - Expert review of …, 2019 - Taylor & Francis
Introduction: Blood draw or collection of other body fluids, known as 'liquid biopsies' are
generally less invasive procedures than tumor biopsies. Cell-free tumor DNA (ctDNA) is …